Start Searching Today!

Type a URL to search registration information about any website

Medtronic Diabetes Sign Up Information

Last Updated:
5/10/2020
Site Encrypted:
Yes
Site Category:
Email Verified:
34/100
Data Held

Email Address

 Email

Your Name

 First Name, Last Name

Your Address

 City, Country

Phone Number

 Mobile Phone

Post-Registration Data

We are still gathering data about this website

Validation

This site did not show evidence of storing passwords in plaintext.

This site does allow secured connections (https)

This site did show a clear way to unsubscribe from their emails

This site does verify your email address.

Membership Emails

Below is a sample of the emails you can expect to receive when signed up to Medtronic Diabetes.

You may have already met your annual deductible—the amount you must pay before your health insurance starts to pay anything. Get your free benefit check today.
View as Web page

 
Medtronic
877-468-1187
REMEMBER,
insurance BENEFITS*
RESET soon.

We''re almost at the end of the year. You may have already met your annual deductible-the amount you must pay before your health insurance plan starts to pay. Get your free benefit check today.

CALL 877-468-1187

(8AM-6PM CT, Monday-Friday)

runner
Couple

what does it mean
for you?

If you have met your deductible, you may be able to upgrade to our new MiniMed™ 770G system for a lower out-of-pocket cost than at other times during the year.

ORDER NOW
EXPLORE THE NEW
MINIMED™ 770G SYSTEM
 
Learn more
 

Always by your side,
Medtronic

Couple

940M23650-011 16NOV2020 ? 2020 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. All other brands are trademarks of a Medtronic company.

*Timing of insurance benefits may vary. Please consult your payer medical policies and guidelines.

Important Safety Information: MiniMed™ 770G System With SmartGuard™ Technology

The MiniMed™ 770G system is intended for continuous delivery of basal insulin (at user selectable rates) and administration of insulin boluses (in user selectable amounts) for the management of type 1 diabetes mellitus in persons two years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed™ 770G System includes SmartGuard™ technology, which can be programmed to automatically adjust delivery of basal insulin based on continuous glucose monitoring (CGM) sensor glucose values (SG) and can suspend delivery of insulin when the SG value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed™ 770G System consists of the following devices: MiniMed™ 770G Insulin Pump, the Guardian™ Link (3) Transmitter, the Guardian™ Sensor (3), one-press serter, the Accu-Chek® Guide Link blood glucose meter, and the AccuChek®Guide Test Strips. The system requires a prescription. The Guardian™ Sensor (3) has not been evaluated and is not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a fingerstick may be required. All therapy adjustments should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian™ Sensor (3).

All therapy adjustments should be based on measurements obtained using the Accu-Chek® Guide Link blood glucose meter and not on values provided by the Guardian™ Sensor (3). Always check the pump display to ensure the glucose result shown agrees with the glucose results shown on the Accu-Chek® Guide Link blood glucose meter. Do not calibrate your CGM device or calculate a bolus using a blood glucose meter result taken from an alternative site. It is not recommended to calibrate your CGM device when sensor or blood glucose values are changing rapidly, e.g., following a meal or physical exercise.

WARNING: Do not use the MiniMed™ 770G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed™ 770G system.

Pump therapy is not recommended for people whose vision or hearing does not allow recognition of pump signals and alarms. Pump therapy is not recommended for people who are unwilling or unable to maintain contact with their healthcare professional. The safety of the MiniMed™ 770G system has not been studied in pregnant women. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult https://www.medtronicdiabetes.com/important-safetyinformation#minimed-770g and the appropriate user guide at https://www.medtronicdiabetes.com/download-library

 
Products Insulin Pump Therapy CareLink™ Software Diabetes.Shop
 
Services Continuous Glucose Monitoring Support Bill Pay
 
 
 
Notice of Privacy Practices Privacy Policy Safety Information


This message was sent to @ from:

Medtronic Diabetes | 18000 Devonshire St | Northridge, CA 91325, USA


Manage your communication preferences
Unsubscribe
 

Registration
Are you over 13?
First name
Last name
Email
Phone (mobile)
City
Country
Are you over 13?
  Yes   
Country / Region
Country / RegionUnited StatesAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaCom
I have read and understand the terms of this marketing authorization. I hereby knowingly and voluntarily authorize Medtronic to use such information for the purposes described in the authorization. AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to
I have read and understand the terms of this phone communications. I consent to receive phone calls and/or artificial or prerecorded voice messages at the phone number(s) provided above sent from or on behalf of Medtronic Diabetes using automated technology. CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d
Data Name Data Type Options
Are you over 13?   Text Box
First name   Text Box
Last name   Text Box
Email   Text Box
Phone (mobile)   Text Box
City   Text Box
Country   Text Box
  option Are you over 13?
  option   Yes   
  dropdown Country / Region
  checklist Country / RegionUnited StatesAfghanistanÅland IslandsAlbaniaAlgeriaAmerican SamoaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustraliaAustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBoliviaBosnia and HerzegovinaBotswanaBouvet IslandBrazilBritish Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanadaCape VerdeCayman IslandsCentral African RepublicChadChileChinaChristmas IslandCocos (Keeling) IslandsColombiaCom
  checklist I have read and understand the terms of this marketing authorization. I hereby knowingly and voluntarily authorize Medtronic to use such information for the purposes described in the authorization. AUTHORIZATION FOR USE OF PROTECTED HEALTH INFORMATION You authorize Medtronic MiniMed, Inc. d/b/a Medtronic Diabetes or its subsidiaries, contractors or representatives to use your personal information, including but not limited to your contact information and health information, for marketing purposes and to
  checklist I have read and understand the terms of this phone communications. I consent to receive phone calls and/or artificial or prerecorded voice messages at the phone number(s) provided above sent from or on behalf of Medtronic Diabetes using automated technology. CONSENT FOR RECEIPT OF PHONE COMMUNICATIONS You consent to receiving phone calls, including pre-recorded and auto-dialed communications, at the phone number(s) submitted above using automated technology from or on behalf of Medtronic MiniMed, Inc. d

Comments about medtronicdiabetes

No Comments
Comment by: admin
Comment on: 01/09/2020